3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 32026-08-26NCT07128199
STOP HCC-GAAD-APAC-ThailandFibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liverEnrolling by invitationNot applicable2026-01-06NCT07319299
The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD.Digestive System Diseases, Insulin Resistance, Nutritional and Metabolic Diseases, cardiovascular disorder, fatty liver disease, glucose metabolism disease, hyperinsulinism, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver diseaseEnrolling by invitationNot applicable2025-05-15NCT06334666